Cargando…

Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach

Antibiotic resistance (AR) is the resistance mechanism pattern in bacteria that evolves over some time, thus protecting the bacteria against antibiotics. AR is due to bacterial evolution to make itself fit to changing environmental conditions in a quest for survival of the fittest. AR has emerged du...

Descripción completa

Detalles Bibliográficos
Autores principales: Gul, Saba, Ahmad, Sajjad, Ullah, Asad, Ismail, Saba, Khurram, Muhammad, Tahir ul Qamar, Muhammad, Hakami, Abdulrahim R., Alkhathami, Ali G., Alrumaihi, Faris, Allemailem, Khaled S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876559/
https://www.ncbi.nlm.nih.gov/pubmed/35214648
http://dx.doi.org/10.3390/vaccines10020189
_version_ 1784658203205697536
author Gul, Saba
Ahmad, Sajjad
Ullah, Asad
Ismail, Saba
Khurram, Muhammad
Tahir ul Qamar, Muhammad
Hakami, Abdulrahim R.
Alkhathami, Ali G.
Alrumaihi, Faris
Allemailem, Khaled S.
author_facet Gul, Saba
Ahmad, Sajjad
Ullah, Asad
Ismail, Saba
Khurram, Muhammad
Tahir ul Qamar, Muhammad
Hakami, Abdulrahim R.
Alkhathami, Ali G.
Alrumaihi, Faris
Allemailem, Khaled S.
author_sort Gul, Saba
collection PubMed
description Antibiotic resistance (AR) is the resistance mechanism pattern in bacteria that evolves over some time, thus protecting the bacteria against antibiotics. AR is due to bacterial evolution to make itself fit to changing environmental conditions in a quest for survival of the fittest. AR has emerged due to the misuse and overuse of antimicrobial drugs, and few antibiotics are now left to deal with these superbug infections. To combat AR, vaccination is an effective method, used either therapeutically or prophylactically. In the current study, an in silico approach was applied for the design of multi-epitope-based vaccines against Providencia rettgeri, a major cause of traveler’s diarrhea. A total of six proteins: fimbrial protein, flagellar hook protein (FlgE), flagellar basal body L-ring protein (FlgH), flagellar hook-basal body complex protein (FliE), flagellar basal body P-ring formation protein (FlgA), and Gram-negative pili assembly chaperone domain proteins, were considered as vaccine targets and were utilized for B- and T-cell epitope prediction. The predicted epitopes were assessed for allergenicity, antigenicity, virulence, toxicity, and solubility. Moreover, filtered epitopes were utilized in multi-epitope vaccine construction. The predicted epitopes were joined with each other through specific GPGPG linkers and were joined with cholera toxin B subunit adjuvant via another EAAAK linker in order to enhance the efficacy of the designed vaccine. Docking studies of the designed vaccine construct were performed with MHC-I (PDB ID: 1I1Y), MHC-II (1KG0), and TLR-4 (4G8A). Findings of the docking study were validated through molecular dynamic simulations, which confirmed that the designed vaccine showed strong interactions with the immune receptors, and that the epitopes were exposed to the host immune system for proper recognition and processing. Additionally, binding free energies were estimated, which highlighted both electrostatic energy and van der Waals forces to make the complexes stable. Briefly, findings of the current study are promising and may help experimental vaccinologists to formulate a novel multi-epitope vaccine against P. rettgeri.
format Online
Article
Text
id pubmed-8876559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88765592022-02-26 Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach Gul, Saba Ahmad, Sajjad Ullah, Asad Ismail, Saba Khurram, Muhammad Tahir ul Qamar, Muhammad Hakami, Abdulrahim R. Alkhathami, Ali G. Alrumaihi, Faris Allemailem, Khaled S. Vaccines (Basel) Article Antibiotic resistance (AR) is the resistance mechanism pattern in bacteria that evolves over some time, thus protecting the bacteria against antibiotics. AR is due to bacterial evolution to make itself fit to changing environmental conditions in a quest for survival of the fittest. AR has emerged due to the misuse and overuse of antimicrobial drugs, and few antibiotics are now left to deal with these superbug infections. To combat AR, vaccination is an effective method, used either therapeutically or prophylactically. In the current study, an in silico approach was applied for the design of multi-epitope-based vaccines against Providencia rettgeri, a major cause of traveler’s diarrhea. A total of six proteins: fimbrial protein, flagellar hook protein (FlgE), flagellar basal body L-ring protein (FlgH), flagellar hook-basal body complex protein (FliE), flagellar basal body P-ring formation protein (FlgA), and Gram-negative pili assembly chaperone domain proteins, were considered as vaccine targets and were utilized for B- and T-cell epitope prediction. The predicted epitopes were assessed for allergenicity, antigenicity, virulence, toxicity, and solubility. Moreover, filtered epitopes were utilized in multi-epitope vaccine construction. The predicted epitopes were joined with each other through specific GPGPG linkers and were joined with cholera toxin B subunit adjuvant via another EAAAK linker in order to enhance the efficacy of the designed vaccine. Docking studies of the designed vaccine construct were performed with MHC-I (PDB ID: 1I1Y), MHC-II (1KG0), and TLR-4 (4G8A). Findings of the docking study were validated through molecular dynamic simulations, which confirmed that the designed vaccine showed strong interactions with the immune receptors, and that the epitopes were exposed to the host immune system for proper recognition and processing. Additionally, binding free energies were estimated, which highlighted both electrostatic energy and van der Waals forces to make the complexes stable. Briefly, findings of the current study are promising and may help experimental vaccinologists to formulate a novel multi-epitope vaccine against P. rettgeri. MDPI 2022-01-25 /pmc/articles/PMC8876559/ /pubmed/35214648 http://dx.doi.org/10.3390/vaccines10020189 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gul, Saba
Ahmad, Sajjad
Ullah, Asad
Ismail, Saba
Khurram, Muhammad
Tahir ul Qamar, Muhammad
Hakami, Abdulrahim R.
Alkhathami, Ali G.
Alrumaihi, Faris
Allemailem, Khaled S.
Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title_full Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title_fullStr Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title_full_unstemmed Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title_short Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
title_sort designing a recombinant vaccine against providencia rettgeri using immunoinformatics approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876559/
https://www.ncbi.nlm.nih.gov/pubmed/35214648
http://dx.doi.org/10.3390/vaccines10020189
work_keys_str_mv AT gulsaba designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT ahmadsajjad designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT ullahasad designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT ismailsaba designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT khurrammuhammad designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT tahirulqamarmuhammad designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT hakamiabdulrahimr designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT alkhathamialig designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT alrumaihifaris designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach
AT allemailemkhaleds designingarecombinantvaccineagainstprovidenciarettgeriusingimmunoinformaticsapproach